Recent News

ADI-PEG 20 is Being Tested on Non-Epithelioid Mesothelioma

January 12, 2024

Polaris Group recently announced an application for a rolling submission of a new mesothelioma treatment. The Biologic License Application is the first step in becoming approved by the Food and[…]

CARD is Working on New Articles to be Released in 2024

January 5, 2024

The Center for Asbestos Related Disease is working on new research articles that will be released throughout this year. They will be focusing on asbestos and autoimmune disease. The articles[…]

Pembrolizumab and Chemotherapy Improve Survival in Patients

December 15, 2023

Pleural mesothelioma, a cancer mainly caused by asbestos, is a hard cancer to treat. Diagnosis usually occurs when it is in a late stage, leading to limited treatment options. New[…]

CIRT Radiation Therapy Beneficial for Lung Cancer Patients

December 8, 2023

Surgery is usually the first choice for patients and doctors for the treatment of early-stage cancer. There are other options though like radiotherapy. A special type of radiotherapy called Carbon-ion[…]

Checkmate743 Showed Higher Toxicity in a Real World Setting

December 1, 2023

A group of Australian patients receiving Checkmate743 therapy saw higher levels of toxicity compared to CheckMate743 clinical trial patients. Checkmate743 consists of a dual treatment of ipilimumab and nivolumab and[…]

A New Biomarker Could Help Doctors Diagnose Mesothelioma

November 17, 2023

A new biomarker has been found for the diagnosis of mesothelioma by scientists in Japan. Information from this research could revolutionize how mesothelioma is diagnosed and treated in the future.[…]

Johnson & Johnson Will Try to File for Bankruptcy for a Third Time

November 10, 2023

Johnson & Johnson may try to file bankruptcy for a third time to address its talc liabilities. The company has failed twice before but is looking again to file for[…]

Inhibiting YB-1 Can Help Improve Mesothelioma Treatments

October 19, 2023

Researchers in Vienna, Austria recently found a protein that could help treat mesothelioma patients. Researchers found the oncoprotein YB-1 which, when targeted, could make pleural mesothelioma more sensitive to chemotherapy[…]

Teachers in Philadelphia are Suing for Being Punished for Asbestos Protest

October 12, 2023

Three teachers recently filed a lawsuit over their first amendment right to publicly demand answers about asbestos inside classrooms.  They claim their rights were violated when they were punished for[…]

There are Stricter Regulations for Manufacturers of Asbestos

October 6, 2023

Now that the final reporting from the U.S. Environmental Protection Agency’s Toxic Substances Control Act is completed, asbestos manufacturers and processors are under stricter regulations. This is all due to[…]

Skip to content